5T4 as a target for immunotherapy in renal cell carcinoma.
Elkord
Eyad
E
Shablak
Alaaeldin
A
Stern
Peter L
PL
Hawkins
Robert E
RE
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology; D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000628:therapy*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy*; D008562:Membrane Glycoproteins / Q000235:genetics* / Q000276:immunology; D019444:Vaccines, DNA
D000911:Antibodies, Monoclonal; D019496:Cancer Vaccines; D008562:Membrane Glycoproteins; C504058:TroVax; D019444:Vaccines, DNA; C063709:trophoblastic glycoprotein 5T4, human